Alberdina de Boer
Senior Executive (CEO, President etc.)
Data updated
Research Footprint
Alberdina de Boer appears in 4 tracked papers (2021–2023), most studied alongside MDMA and Placebo, across PTSD, Safety & Risk Management and Anxiety Disorders.
Most-cited paper: MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study (942 citations).
Frequent co-authors: Lisa Jerome, Michael Mithoefer and Rick Doblin.
Background & Research
Alberdina de Boer appears as an author on multiple MDMA-related publications, including the 2023 and 2024 phase 3 PTSD trial papers and FAERS-based safety analyses. A current professional profile lists her as a Senior Executive at Tulip Medical Consulting LLC in Port Townsend, United States.
Key Impact
She is listed as an author on key MAPS/MDMA phase 3 PTSD trial publications and related MDMA safety analyses, indicating a notable role in psychedelic medicine research and development.
Collaboration Network
15 collaborators· click a node to visit their profile
Full network →